Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/q32-bio-announces-closing-of-merger-with-homology-medicines-and-concurrent-private-placement-of-42-million-302098557.html
https://www.globenewswire.com/news-release/2024/03/18/2848184/0/en/Homology-Medicines-Declares-Distribution-to-Common-Stockholders.html
https://www.globenewswire.com//news-release/2024/01/03/2803627/0/en/Homology-Medicines-Receives-NASDAQ-Notification-Regarding-Minimum-Bid-Price-Deficiency.html
https://www.globenewswire.com//news-release/2023/11/16/2781720/0/en/Q32-Bio-and-Homology-Medicines-Announce-Merger-Agreement.html
https://www.globenewswire.com//news-release/2023/11/14/2780577/0/en/Homology-Medicines-Reports-Third-Quarter-2023-Financial-Results.html
https://www.globenewswire.com/news-release/2023/08/14/2724999/0/en/Homology-Medicines-Reports-Second-Quarter-2023-Financial-Results-and-Recent-Highlights.html
https://www.globenewswire.com/news-release/2023/07/27/2712687/0/en/Homology-Medicines-Announces-Plan-to-Evaluate-Strategic-Options-for-the-Company-and-its-Genetic-Medicines-Programs-including-HMI-103-Gene-Editing-Candidate-for-PKU.html
https://www.globenewswire.com/news-release/2023/07/27/2712667/0/en/Homology-Medicines-Announces-Encouraging-Initial-Data-from-First-Dose-Level-in-the-pheEDIT-Trial-Evaluating-Gene-Editing-Candidate-HMI-103-in-Adults-with-Classical-PKU.html
https://www.globenewswire.com/news-release/2023/05/16/2669926/0/en/Homology-Medicines-Announces-First-Data-from-IND-Enabling-Studies-with-GTx-mAb-Candidate-HMI-104-for-PNH-Which-Demonstrated-Sustained-Expression-of-Functional-C5mAb-Levels-at-the-A.html
https://www.globenewswire.com/news-release/2023/05/11/2667297/0/en/Homology-Medicines-Reports-First-Quarter-2023-Financial-Results-and-Recent-Highlights.html